CombiGene´s lead project CG01 has received funding from the European Union´s Horizon 2020 research and innovation programme

CombiGene featured in an article in Nature, one of the world’s leading scientific journals

Dec 14, 2018

The latest number of Nature (Vol. 564, Issue 7735, 13 December 2018) features CombiGene’s operations, and the possibilities of using gene therapy to treat epilepsy. Both CombiGene’s scientific founder, Professor Merab Kokaia, and CEO Jan Nilsson, are quoted.

“CombiGene being featured in Nature like this makes me incredibly happy and proud. It is a clear sign that our research and development is beginning to attract international attention. With this fantastic end of 2018, we will start 2019 stronger and even more inspired,” says CombiGene CEO Jan Nilsson.

Read the entire article here:
https://www.nature.com/magazine-assets/d41586-018-07644-y/d41586-018-07644-y.pdf

Press release >>